SlideShare a Scribd company logo
Adverse drug reactions: the role of case reports Jeff Aronson Reader in Clinical Pharmacology,  Department of Primary Health Care, Oxford President, British Pharmacological Society Meyler’s Side Effects of Drugs   Side Effects of Drugs Annuals Editor-in-Chief
 
Types of adverse drug reactions reports in the world literature
Reasons for publishing anecdotes of adverse drug reactions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reports of suspected adverse effects of mestranol and ethinylestradiol to the then Committee on Safety of Drugs 942 reports 88 PEs 854 others Inman, WH. “Don’t Tell the Patient”, 1999 63 441 Mestranol 25 413 Ethinylestradiol
Products containing considerable amounts of glycyrrhizinic acid Confectionery: Liquorice all sorts Torpedos Blackcurrant Pomfret (Pontefract) cakes Servez vous Sorbits chewing gum Stimorol chewing gum All types of liquorice root: Russian, Iranian, Chinese, Turkish, Afghan, and unknown origin Health products: Liquirizia naturale Liquorice flavoured diet gum Throat pearls Liquorice flavoured cough mixtures Herbal cough mixtures Antibron tablets Liquorice tea Chewing tobacco Alcoholic drinks:  Belgian beers,  pastis, anisettes–raki, ouzo, Pernod
Reasons for publishing anecdotes of adverse drug reactions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Proof
Joseph Berkson (1899-1982) “ Scientist, statistical philosopher, innovator, and much loved curmudgeon” Logit (J Am Stat Assoc 1944; 39: 361) Berkson’s bias (Biometrics Bull 1946; 2: 47-53)  Berkson [regression] error model (J Am Stat Assoc 1950; 45: 164-80) Interocular traumatic impact
Between-the-eyes adverse effects
Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite   Intrinsic: Deposition in nails, teeth Corneal microprecipitates Crystal-storing histiocytosis
Eiferman et al. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J Cataract Refract Surg 2001; 27(10): 1701-2
Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite  2. A specific anatomical location or pattern of injury  Cytotoxic drug extravasation Intrathecal administration Oral ulceration Oesophageal ulceration
Brazier et al. Ecstasy related periodontitis and mucosal ulceration—a case report. Br Dent J 2003; 194(4): 197-9
Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite  2. A specific anatomical location or pattern of injury  3. Physiological dysfunction or direct tissue damage demonstrable by physicochemical testing  Oligohidrosis Photosensitivity Taste disturbance Dry mouth
Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite  2. A specific anatomical location or pattern of injury  3. Physiological dysfunction or direct tissue damage demonstrable by physicochemical testing  4.  Infection, due either to the administration of an infective agent as the therapeutic substance or to demonstrable contamination   BCG, mumps
Trevenzoli et al. Sepsis and granulomatous hepatitis after bacillus Calmette-Guérin intravesical installation.  J Infect 2004; 48(4): 363-7
A crime scene analogy Distinctive outcome  Recognizing a modus operandi Culprit’s fingerprints found at the scene of the crime Infection-related Culprit incriminated by recreating the crime scene Physicochemical dysfunction or tissue damage Culprit caught at the scene of the crime and seen committing it Specific anatomical location or pattern of injury Culprit caught at the scene of the crime Extracellular or intracellular tissue deposition Crime scene analogy Category
 
Comprehensiveness and adverse  effects of amiodarone ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Meta-analysis (n = 4153) 1.80 1.20 1.00 0.96 0.49 0.47 0.47 0.35 Anecdotes (n = 357) 0.11 0.44 1.00 0.46 0.26 0.02 0.10 0.26 UMC (n = 7043) 0.44 1.70 1.00 0.89 0.77 0.49 0.20 1.04 Loke, Derry, Aronson Br J Clin Pharmacol; 2004: 57: 616-21
http://www.who-umc.org Database of 4.7 million case reports 94 countries 300,000 new records per year
[object Object],[object Object],[object Object],[object Object]
 
Proportional Reporting Ratio (PRR) Produces a numerical “signal score” by which drug-event pairs can be ranked D C All adverse events reports in database B A Reports of the event of interest All other drugs in database Drug under review PRR  = A / C B / D
Statistics in Medicine 2009; 28: 1774–92
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive reporting of suspected adverse effects Age Sex Weight Ethnicity Diagnoses Allergies Drug treatment (current/past) Family history Social history Severity Time-course Withdrawal Rechallenge Diagnostic tests Plasma concentrations Animal/in vtiro evidence Treatment Outcome Assessment of likelihood Drug Points in BMJ January 2001 to October 2002 (BMJ 2003; 326: 1346) 35 reports; 48 patients Of 19 desiderata: 9 (5-12) Of 14 yellow card items: 9 (4-12) Of 14 MedWatch items: 8 (3-11)
Aronson, BMJ 2003; 326: 1346; e-appendix
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Discussion Likelihood of a true association Reasons for implicating the drug Why other drugs were not responsible Elimination of other possible causes Review of previous cases Methods of diagnosis Possible mechanisms Possible forms of management Implications for clinical practice Hypotheses generated
 
Conclusions Anecdotal reports of suspected adverse drug reactions make up a large propotion of the published literature A few drug-event pairs are interocular Most drug-event pairs are not and need large numbers of reports for signal detection Signals can be detected from accumulated anecdotes; they should then be interpreted clinically and verification attempted The quality of reporting is currently poor and should be improved; guidelines may help
Raymond Wolfinger:  “ The plural of anecdote is data”

More Related Content

What's hot

Bio variance j_scheiber_bioit_repurposingworkshop2013_draft
Bio variance j_scheiber_bioit_repurposingworkshop2013_draftBio variance j_scheiber_bioit_repurposingworkshop2013_draft
Bio variance j_scheiber_bioit_repurposingworkshop2013_draft
Josef Scheiber
 
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
iosrjce
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
Michel Dumontier
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
Michel Dumontier
 
Pharmacogenomics as a tool for Personalized medicine
Pharmacogenomics as a tool for Personalized medicinePharmacogenomics as a tool for Personalized medicine
Pharmacogenomics as a tool for Personalized medicine
PharmCare Research Group USM
 
History and overview of pharmacovigilance adverse event..
History and overview of pharmacovigilance adverse event..History and overview of pharmacovigilance adverse event..
History and overview of pharmacovigilance adverse event..
DHIRAJMALEKAR1
 
Ethical considerations on pharmacogenomics
Ethical considerations on pharmacogenomicsEthical considerations on pharmacogenomics
Ethical considerations on pharmacogenomicsEmilio Mordini
 
First in Human dose
First in Human  doseFirst in Human  dose
First in Human dose
Ramakanth Gadepalli
 
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Khalid Ghaznavi
 
Drug reaction with eosinophila and systemic symptoms
Drug reaction with eosinophila and systemic symptomsDrug reaction with eosinophila and systemic symptoms
Drug reaction with eosinophila and systemic symptoms
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Drug repurposing
Drug repurposingDrug repurposing
Personalized Medicine: A Tailor Made Solution
Personalized Medicine: A Tailor Made SolutionPersonalized Medicine: A Tailor Made Solution
Personalized Medicine: A Tailor Made Solution
Advancells Stem Cell Therapies
 
Drug Safety Alert 5 Ketoconazole
Drug Safety Alert 5 KetoconazoleDrug Safety Alert 5 Ketoconazole
Drug Safety Alert 5 Ketoconazole
Obaid Ali / Roohi B. Obaid
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
Mehak AggarwAl
 
Dosage form for Personalized medicine
Dosage form for Personalized medicine Dosage form for Personalized medicine
Dosage form for Personalized medicine
ROHIT
 
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Richard Boyce, PhD
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
Ashishkumar Baheti
 
24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
 
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
Rahul Kadam
 
Ltfx vs.drfx
Ltfx vs.drfxLtfx vs.drfx
Ltfx vs.drfx
Avaleks-Kiev
 

What's hot (20)

Bio variance j_scheiber_bioit_repurposingworkshop2013_draft
Bio variance j_scheiber_bioit_repurposingworkshop2013_draftBio variance j_scheiber_bioit_repurposingworkshop2013_draft
Bio variance j_scheiber_bioit_repurposingworkshop2013_draft
 
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
Evaluation of cutaneous adverse drug reactions due to antimicrobial agents: A...
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
 
Pharmacogenomics as a tool for Personalized medicine
Pharmacogenomics as a tool for Personalized medicinePharmacogenomics as a tool for Personalized medicine
Pharmacogenomics as a tool for Personalized medicine
 
History and overview of pharmacovigilance adverse event..
History and overview of pharmacovigilance adverse event..History and overview of pharmacovigilance adverse event..
History and overview of pharmacovigilance adverse event..
 
Ethical considerations on pharmacogenomics
Ethical considerations on pharmacogenomicsEthical considerations on pharmacogenomics
Ethical considerations on pharmacogenomics
 
First in Human dose
First in Human  doseFirst in Human  dose
First in Human dose
 
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
 
Drug reaction with eosinophila and systemic symptoms
Drug reaction with eosinophila and systemic symptomsDrug reaction with eosinophila and systemic symptoms
Drug reaction with eosinophila and systemic symptoms
 
Drug repurposing
Drug repurposingDrug repurposing
Drug repurposing
 
Personalized Medicine: A Tailor Made Solution
Personalized Medicine: A Tailor Made SolutionPersonalized Medicine: A Tailor Made Solution
Personalized Medicine: A Tailor Made Solution
 
Drug Safety Alert 5 Ketoconazole
Drug Safety Alert 5 KetoconazoleDrug Safety Alert 5 Ketoconazole
Drug Safety Alert 5 Ketoconazole
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 
Dosage form for Personalized medicine
Dosage form for Personalized medicine Dosage form for Personalized medicine
Dosage form for Personalized medicine
 
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
Toward semantic modeling of pharmacogenomic knowledge for clinical and transl...
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
 
24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
 
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
 
Ltfx vs.drfx
Ltfx vs.drfxLtfx vs.drfx
Ltfx vs.drfx
 

Similar to Adverse drug reactions: the role of case reports - Jeff Aronson

Adverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and ClassificationAdverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and Classification
Venkateswaramurthy N
 
Pharmacogenomics Dissemination of Information
Pharmacogenomics Dissemination of InformationPharmacogenomics Dissemination of Information
Pharmacogenomics Dissemination of Information
Laura Robusto
 
Drug risk assessment 23 4-2010
Drug risk assessment 23 4-2010Drug risk assessment 23 4-2010
Drug risk assessment 23 4-2010RobHeerdink
 
Animal Experiments and Alternatives
Animal Experiments and AlternativesAnimal Experiments and Alternatives
Animal Experiments and Alternatives
Andrew Knight
 
EVALUATION OF DRUG EFFECTS.pdf
EVALUATION OF DRUG EFFECTS.pdfEVALUATION OF DRUG EFFECTS.pdf
EVALUATION OF DRUG EFFECTS.pdf
RITHIKA R S
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Dev
guest41e570
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Devguest41e570
 
01 conspectus of disease
01 conspectus of disease01 conspectus of disease
01 conspectus of disease
Prabesh Raj Jamkatel
 
Session 2 part 3
Session 2 part 3Session 2 part 3
Session 2 part 3plmiami
 
Drug Devel Ment
Drug Devel MentDrug Devel Ment
Drug Devel Ment
Med Bee
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilance
siddemsetty nikhil
 
drugoverdose.pptx
drugoverdose.pptxdrugoverdose.pptx
drugoverdose.pptx
Sruthi Meenaxshi
 
Poisoning in Children by Dr Shamavu Gabriel .pptx
Poisoning in Children by Dr Shamavu Gabriel .pptxPoisoning in Children by Dr Shamavu Gabriel .pptx
Poisoning in Children by Dr Shamavu Gabriel .pptx
Gabriel Shamavu
 
Toxicology investigation of a poison death
Toxicology investigation of a poison deathToxicology investigation of a poison death
Toxicology investigation of a poison death
reiamameer
 
Drug development
Drug developmentDrug development
Drug developmentraj kumar
 
Drug development
Drug developmentDrug development
Drug developmentraj kumar
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studies
karan chainani
 

Similar to Adverse drug reactions: the role of case reports - Jeff Aronson (20)

Adverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and ClassificationAdverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and Classification
 
Pharmacogenomics Dissemination of Information
Pharmacogenomics Dissemination of InformationPharmacogenomics Dissemination of Information
Pharmacogenomics Dissemination of Information
 
Drug risk assessment 23 4-2010
Drug risk assessment 23 4-2010Drug risk assessment 23 4-2010
Drug risk assessment 23 4-2010
 
Animal Experiments and Alternatives
Animal Experiments and AlternativesAnimal Experiments and Alternatives
Animal Experiments and Alternatives
 
Drug overdose poisoning
Drug overdose poisoningDrug overdose poisoning
Drug overdose poisoning
 
EVALUATION OF DRUG EFFECTS.pdf
EVALUATION OF DRUG EFFECTS.pdfEVALUATION OF DRUG EFFECTS.pdf
EVALUATION OF DRUG EFFECTS.pdf
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Dev
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Dev
 
01 conspectus of disease
01 conspectus of disease01 conspectus of disease
01 conspectus of disease
 
Session 2 part 3
Session 2 part 3Session 2 part 3
Session 2 part 3
 
Drug Devel Ment
Drug Devel MentDrug Devel Ment
Drug Devel Ment
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilance
 
ppt
pptppt
ppt
 
drugoverdose.pptx
drugoverdose.pptxdrugoverdose.pptx
drugoverdose.pptx
 
Poisoning in Children by Dr Shamavu Gabriel .pptx
Poisoning in Children by Dr Shamavu Gabriel .pptxPoisoning in Children by Dr Shamavu Gabriel .pptx
Poisoning in Children by Dr Shamavu Gabriel .pptx
 
Toxicology investigation of a poison death
Toxicology investigation of a poison deathToxicology investigation of a poison death
Toxicology investigation of a poison death
 
Drug development
Drug developmentDrug development
Drug development
 
Drug development
Drug developmentDrug development
Drug development
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studies
 
Final Poster
Final PosterFinal Poster
Final Poster
 

More from Cases Network

Healthtalkonline.org - Ann McPherson
Healthtalkonline.org - Ann McPhersonHealthtalkonline.org - Ann McPherson
Healthtalkonline.org - Ann McPhersonCases Network
 
Introducing The Cases Database - Elizabeth Slade
Introducing The Cases Database - Elizabeth SladeIntroducing The Cases Database - Elizabeth Slade
Introducing The Cases Database - Elizabeth SladeCases Network
 
Web 2.0 and the future of health care - Paul Hodgkin
Web 2.0 and the future of health care - Paul HodgkinWeb 2.0 and the future of health care - Paul Hodgkin
Web 2.0 and the future of health care - Paul HodgkinCases Network
 
Case Reports, Infectious Diseases and the Developing World - Geoffrey Pasvol
Case Reports, Infectious Diseases and the Developing World - Geoffrey PasvolCase Reports, Infectious Diseases and the Developing World - Geoffrey Pasvol
Case Reports, Infectious Diseases and the Developing World - Geoffrey PasvolCases Network
 
The benefits and risks of case reports - Iain Chalmers
The benefits and risks of case reports - Iain ChalmersThe benefits and risks of case reports - Iain Chalmers
The benefits and risks of case reports - Iain ChalmersCases Network
 
EBM or cases or both? - Tom Jefferson
EBM or cases or both? - Tom JeffersonEBM or cases or both? - Tom Jefferson
EBM or cases or both? - Tom JeffersonCases Network
 
Change and Canonicity in Clinical Case Reports - Brian Hurwitz
Change and Canonicity in Clinical Case Reports - Brian HurwitzChange and Canonicity in Clinical Case Reports - Brian Hurwitz
Change and Canonicity in Clinical Case Reports - Brian HurwitzCases Network
 
Keynote _ David Weatherall
Keynote _ David WeatherallKeynote _ David Weatherall
Keynote _ David WeatherallCases Network
 

More from Cases Network (8)

Healthtalkonline.org - Ann McPherson
Healthtalkonline.org - Ann McPhersonHealthtalkonline.org - Ann McPherson
Healthtalkonline.org - Ann McPherson
 
Introducing The Cases Database - Elizabeth Slade
Introducing The Cases Database - Elizabeth SladeIntroducing The Cases Database - Elizabeth Slade
Introducing The Cases Database - Elizabeth Slade
 
Web 2.0 and the future of health care - Paul Hodgkin
Web 2.0 and the future of health care - Paul HodgkinWeb 2.0 and the future of health care - Paul Hodgkin
Web 2.0 and the future of health care - Paul Hodgkin
 
Case Reports, Infectious Diseases and the Developing World - Geoffrey Pasvol
Case Reports, Infectious Diseases and the Developing World - Geoffrey PasvolCase Reports, Infectious Diseases and the Developing World - Geoffrey Pasvol
Case Reports, Infectious Diseases and the Developing World - Geoffrey Pasvol
 
The benefits and risks of case reports - Iain Chalmers
The benefits and risks of case reports - Iain ChalmersThe benefits and risks of case reports - Iain Chalmers
The benefits and risks of case reports - Iain Chalmers
 
EBM or cases or both? - Tom Jefferson
EBM or cases or both? - Tom JeffersonEBM or cases or both? - Tom Jefferson
EBM or cases or both? - Tom Jefferson
 
Change and Canonicity in Clinical Case Reports - Brian Hurwitz
Change and Canonicity in Clinical Case Reports - Brian HurwitzChange and Canonicity in Clinical Case Reports - Brian Hurwitz
Change and Canonicity in Clinical Case Reports - Brian Hurwitz
 
Keynote _ David Weatherall
Keynote _ David WeatherallKeynote _ David Weatherall
Keynote _ David Weatherall
 

Recently uploaded

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 

Adverse drug reactions: the role of case reports - Jeff Aronson

  • 1. Adverse drug reactions: the role of case reports Jeff Aronson Reader in Clinical Pharmacology, Department of Primary Health Care, Oxford President, British Pharmacological Society Meyler’s Side Effects of Drugs Side Effects of Drugs Annuals Editor-in-Chief
  • 2.  
  • 3. Types of adverse drug reactions reports in the world literature
  • 4.
  • 5. Reports of suspected adverse effects of mestranol and ethinylestradiol to the then Committee on Safety of Drugs 942 reports 88 PEs 854 others Inman, WH. “Don’t Tell the Patient”, 1999 63 441 Mestranol 25 413 Ethinylestradiol
  • 6. Products containing considerable amounts of glycyrrhizinic acid Confectionery: Liquorice all sorts Torpedos Blackcurrant Pomfret (Pontefract) cakes Servez vous Sorbits chewing gum Stimorol chewing gum All types of liquorice root: Russian, Iranian, Chinese, Turkish, Afghan, and unknown origin Health products: Liquirizia naturale Liquorice flavoured diet gum Throat pearls Liquorice flavoured cough mixtures Herbal cough mixtures Antibron tablets Liquorice tea Chewing tobacco Alcoholic drinks: Belgian beers, pastis, anisettes–raki, ouzo, Pernod
  • 7.
  • 8. Joseph Berkson (1899-1982) “ Scientist, statistical philosopher, innovator, and much loved curmudgeon” Logit (J Am Stat Assoc 1944; 39: 361) Berkson’s bias (Biometrics Bull 1946; 2: 47-53) Berkson [regression] error model (J Am Stat Assoc 1950; 45: 164-80) Interocular traumatic impact
  • 10. Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite Intrinsic: Deposition in nails, teeth Corneal microprecipitates Crystal-storing histiocytosis
  • 11. Eiferman et al. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J Cataract Refract Surg 2001; 27(10): 1701-2
  • 12. Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite 2. A specific anatomical location or pattern of injury Cytotoxic drug extravasation Intrathecal administration Oral ulceration Oesophageal ulceration
  • 13. Brazier et al. Ecstasy related periodontitis and mucosal ulceration—a case report. Br Dent J 2003; 194(4): 197-9
  • 14. Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite 2. A specific anatomical location or pattern of injury 3. Physiological dysfunction or direct tissue damage demonstrable by physicochemical testing Oligohidrosis Photosensitivity Taste disturbance Dry mouth
  • 15. Between-the-eyes adverse effects 1. Extrinsic or intrinsic tissue deposition of the drug or a metabolite 2. A specific anatomical location or pattern of injury 3. Physiological dysfunction or direct tissue damage demonstrable by physicochemical testing 4. Infection, due either to the administration of an infective agent as the therapeutic substance or to demonstrable contamination BCG, mumps
  • 16. Trevenzoli et al. Sepsis and granulomatous hepatitis after bacillus Calmette-Guérin intravesical installation. J Infect 2004; 48(4): 363-7
  • 17. A crime scene analogy Distinctive outcome Recognizing a modus operandi Culprit’s fingerprints found at the scene of the crime Infection-related Culprit incriminated by recreating the crime scene Physicochemical dysfunction or tissue damage Culprit caught at the scene of the crime and seen committing it Specific anatomical location or pattern of injury Culprit caught at the scene of the crime Extracellular or intracellular tissue deposition Crime scene analogy Category
  • 18.  
  • 19.
  • 20. http://www.who-umc.org Database of 4.7 million case reports 94 countries 300,000 new records per year
  • 21.
  • 22.  
  • 23. Proportional Reporting Ratio (PRR) Produces a numerical “signal score” by which drug-event pairs can be ranked D C All adverse events reports in database B A Reports of the event of interest All other drugs in database Drug under review PRR = A / C B / D
  • 24. Statistics in Medicine 2009; 28: 1774–92
  • 25.  
  • 26.  
  • 27.  
  • 28.  
  • 29.  
  • 30.  
  • 31.  
  • 32.  
  • 33.  
  • 34.  
  • 35.  
  • 36.  
  • 37.  
  • 38.  
  • 39. Comprehensive reporting of suspected adverse effects Age Sex Weight Ethnicity Diagnoses Allergies Drug treatment (current/past) Family history Social history Severity Time-course Withdrawal Rechallenge Diagnostic tests Plasma concentrations Animal/in vtiro evidence Treatment Outcome Assessment of likelihood Drug Points in BMJ January 2001 to October 2002 (BMJ 2003; 326: 1346) 35 reports; 48 patients Of 19 desiderata: 9 (5-12) Of 14 yellow card items: 9 (4-12) Of 14 MedWatch items: 8 (3-11)
  • 40. Aronson, BMJ 2003; 326: 1346; e-appendix
  • 41.
  • 42. Discussion Likelihood of a true association Reasons for implicating the drug Why other drugs were not responsible Elimination of other possible causes Review of previous cases Methods of diagnosis Possible mechanisms Possible forms of management Implications for clinical practice Hypotheses generated
  • 43.  
  • 44. Conclusions Anecdotal reports of suspected adverse drug reactions make up a large propotion of the published literature A few drug-event pairs are interocular Most drug-event pairs are not and need large numbers of reports for signal detection Signals can be detected from accumulated anecdotes; they should then be interpreted clinically and verification attempted The quality of reporting is currently poor and should be improved; guidelines may help
  • 45. Raymond Wolfinger: “ The plural of anecdote is data”